397 related articles for article (PubMed ID: 34508759)
1. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance.
Raei N; Safaralizadeh R; Hesseinpourfeizi M; Yazdanbod A; Pourfarzi F; Latifi-Navid S
Life Sci; 2021 Nov; 284():119933. PubMed ID: 34508759
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
Abu N; Hon KW; Jeyaraman S; Jamal R
Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
[TBL] [Abstract][Full Text] [Related]
5. An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on microRNA-195.
Davoodvandi A; Rafiyan M; Asemi Z; Matini SA
Pathol Res Pract; 2023 Aug; 248():154680. PubMed ID: 37467635
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
7. Competitive endogenous network of lncRNA, miRNA, and mRNA in the chemoresistance of gastrointestinal tract adenocarcinomas.
Raziq K; Cai M; Dong K; Wang P; Afrifa J; Fu S
Biomed Pharmacother; 2020 Oct; 130():110570. PubMed ID: 32763816
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
9. The role of miRNAs and lncRNAs in conferring resistance to doxorubicin.
Taheri M; Mahmud Hussen B; Tondro Anamag F; Shoorei H; Dinger ME; Ghafouri-Fard S
J Drug Target; 2022 Jan; 30(1):1-21. PubMed ID: 33788650
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and lncRNAs in gastrointestinal cancers.
Huang L; Wang W; Hu Z; Guan C; Li W; Jiang X
Pathol Res Pract; 2019 Dec; 215(12):152687. PubMed ID: 31640897
[TBL] [Abstract][Full Text] [Related]
11. LncRNA as a multifunctional regulator in cancer multi-drug resistance.
He J; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
Mol Biol Rep; 2021 Aug; 48(8):1-15. PubMed ID: 34333735
[TBL] [Abstract][Full Text] [Related]
12. Systematic study of novel lncRNAs in different gastrointestinal cancer cells.
Cao B; Song N; Zhang M; Di C; Yang Y; Lu Y; Chen R; Lu ZJ; Guo M
Discov Med; 2016 Mar; 21(115):159-71. PubMed ID: 27115166
[TBL] [Abstract][Full Text] [Related]
13. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data.
Gao Y; Shang S; Guo S; Li X; Zhou H; Liu H; Sun Y; Wang J; Wang P; Zhi H; Li X; Ning S; Zhang Y
Nucleic Acids Res; 2021 Jan; 49(D1):D1251-D1258. PubMed ID: 33219685
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between the lncRNA UCA1 and microRNAs in cancer.
Xuan W; Yu H; Zhang X; Song D
FEBS Lett; 2019 Aug; 593(15):1901-1914. PubMed ID: 31166011
[TBL] [Abstract][Full Text] [Related]
15. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets.
Zhang FF; Luo YH; Wang H; Zhao L
World J Gastroenterol; 2016 Oct; 22(39):8735-8749. PubMed ID: 27818589
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNAs in Gastrointestinal Cancer: Tumor Suppression Versus Tumor Promotion.
Khajehdehi M; Khalaj-Kondori M; Ghasemi T; Jahanghiri B; Damaghi M
Dig Dis Sci; 2021 Feb; 66(2):381-397. PubMed ID: 32185664
[TBL] [Abstract][Full Text] [Related]
18. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
19. Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant.
Zhao X; Tang DY; Zuo X; Zhang TD; Wang C
J Cell Physiol; 2019 Nov; 234(11):19886-19894. PubMed ID: 30950060
[TBL] [Abstract][Full Text] [Related]
20. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
